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To cope with the life-threatening crisis of a DNA interstrand cross-link (ICL), human cells must invoke the Fanconi anemia (FA) DNA repair pathway. The FA pathway is a multistep repair process, requiring multiple nucleolytic incisions and translesion DNA synthesis. Recent work from four laboratories has identified a novel FA-associated nuclease, FAN1, that binds directly to monoubiquitinated FANCD2, resolving a decade-long puzzle regarding the function of this FANCD2 modification.
DNA interstrand cross-links (ICLs) create a serious threat to cell survival by posing a complete blockade to DNA replication and transcription. The molecular basis of ICL repair has therefore drawn increasing attention in the field of DNA repair. Fanconi anemia (FA) is a recessive genetic disorder, and the thirteen known FA genes encode proteins that cooperate in ICL repair [1] [2] [3] [4] . Eight of the FA proteins comprise a multisubunit ubiquitin E3 ligase complex (referred to as FA core complex). This ligase monoubiquitinates the heterodimeric substrate FANCD2-FANCI, a surrogate marker of the activation of the FA pathway 5, 6 . Downstream FA proteins, such as the products of the FANC-D1, J and N genes, are also required for the resolution of ICLs. A possible 14th FA gene, RAD51C, has recently been identified 7 .
The underlying molecular mechanism of ICL repair by the FA pathway has long remained elusive. Recently, a cell-free system derived from Xenopus eggs has elucidated important general principles of this mechanism 8, 9 . ICL repair involves nucleolytic incisions on both sides of the cross-link when two replication forks converge on the ICL. The unhooked cross-link allows the bypass of the lesion by a DNA polymerase, followed by homologous recombination, which completes the repair. Importantly, these studies in the Xenopus system show that the monoubiquitinated FANCD2-FANCI complex is required to promote both the nucleolytic incision step and the translesion bypass step, but the sequence of the steps and the identity of the nucleases have remained largely a mystery. Recent work from four laboratories has at least partially resolved this mystery by identifying a novel FA-associated nuclease, FAN1, and demonstrating its essential role in the FA pathway [10] [11] [12] [13] .
FAN1 was discovered independently using three different approaches, including bioinformatics searching for nucleases containing ubiquitin-binding domain 12, 13 , a MS-based proteomic approach for deciphering proteinprotein interaction 11 and a genome-wide small hairpin RNA screen for sensitivity to cross-linking agents 10 . Originally known as human KIAA1018, FAN1 contains a conserved nuclease domain at its C terminus, which endows the protein with endonuclease and 5′-to-3′ exonuclease activity. Notably, FAN1 shows a preference for a 5′-flap DNA substrate and shows the opposite polarity to the two endonucleases previously implicated in ICL processing, MUS81/EME1 and XPF/ERCC1, Monoubiqutination of FANCD2 and PCNA in ICL repair. ICL damage activates monoubiquitination of FANCD2 and PCNA by the E3 ligases (FA core complex or RAD18, respectively). These modifications lead to the recruitment of nucleases FAN1 or SNM1A, respectively, via their UBZ domains, and these nucleases may be involved in subsequent incisions and/or excision steps during ICL repair, a process with participation of multiple DNA repair pathways, including homologous recombination (HR), translesion synthesis (TLS) and nucleotide excision repair (NER). Similarly, the UBZ or ubiquitin-binding motif (UBM) containing TLS DNA polymerases, such as Rev1 and Pol η, may be recruited to monoubiquitinated FANCD2 or PCNA and, in turn, may participate in the repair. The removal of the ubiquitin moiety by the USP1-UAF1 deubiquitinating enzyme complex is also required for ICL repair. Ub, ubiquitin.
which both preferentially cleave 3′-flaps 14 . Depletion of FAN1 leads to increased cellular sensitivity to DNA cross-linking agents. This ICL hypersensitivity can be rescued by wild-type FAN1 but not by mutants harboring point mutations at the nuclease domain, suggesting that the nuclease activity of FAN1 is required for ICL repair. The link between FAN1 and the FA pathway is mediated by monoubiquitinated FANCD2-FANCI and the ubiquitin-binding zinc finger (UBZ) domain at the N terminus of FAN1. FAN1 interaction with FANCD2-FANCI is abolished by disrupting the UBZ domain of FAN1. Upon ICL damage, FAN1 is recruited to nuclear foci by monoubiquitinated FANCD2, whereas a FANCD2 mutant that cannot be ubiquitinated (K561R) fails to complete this event.
The discovery of FAN1 provides a better understanding of how the FA pathway regulates ICL repair (Fig. 1) . Cross-link repair is initiated by the stalling of one replication fork on each side, 20-40 nucleotides from the ICL. This stalled structure can be recognized by FANCM and its binding partners FAAP24 and MHF 15, 16 . The FANCM complex then recruits the FA core complex to the damage site and simultaneously activates ataxia telangiectasia and rad-3-related (ATR) kinase and its interaction protein (ATRIP) via the recruitment of replication protein A (RPA) 17 . ATR phosphorylates FA pathway components and promotes FANCD2 monoubiquitination, and one of the forks continues to progress to the cross-link site. By the time the fork reaches position -1, FANCD2 has been monoubiquitinated by the FA core complex. In turn, monoubiquitinated FANCD2-FANCI recruits FAN1 to the damage site, where FAN1 performs nucleolytic incisions and promotes the unhooking of the cross-link, allowing lesion bypass by translesion synthesis (TLS) polymerases. Given its exonuclease activity, FAN1 may also be involved in later steps in this model, such as DNA excision and homologous recombination.
Regardless of the actual mechanism, it is clear that multiple nucleases act at multiple steps in ICL repair (Fig. 1) . First, in the ICL unhooking step, MUS81/EME1 acts alone or in conjunction with FAN1 (or perhaps with some other, unidentified nuclease). Second, the unhooked oligonucleotide may be trimmed by 5′-and 3′-exonuclease activities to allow the TLS polymerase to proceed; the 5′-to-3′ exonuclease activity of FAN1 may contribute to this step. Third, the blunt-ended double-strand breaks, generated by replication through the singlestrand gap, must be resected to generate the necessary 3′-overhang and to allow strand invasion and homologous recombination to occur; despite its function in homologous recombination repair, FAN1 does not appear to be involved in this part of the process 11, 12 . Finally, at a later step of homologous recombination, the D-loop structure created by strand invasion may be incised by FAN1, using its 5′-exonuclease activity. The resulting 5′ end may be ligated to the extended invading strand, which results in the regeneration of an intact replication fork, where DNA replication can restart.
Although the identity of the specific nuclease at each step is unclear, several new candidate nucleases are evident. For instance, the SNM1A nuclease appears to have a direct role in ICL repair. SNM1A-deficient cells are hypersensitive to ICL-inducing agents 18, 19 . Also, ICLs can lead to monoubiquitination of proliferating cell nuclear antigen (PCNA) by RAD18, generating monoubiquitinated PCNA, which will recruit the UBZ-containing SNM1A to the site of ICL for repair 20 . The SNM1A exonuclease activity 18 may contribute to ICL repair, perhaps by trimming the unhooked oligonucleotide and therefore allowing the TLS step to occur.
Hence, SNM1A recruitment may be analogous to FAN1 recruitment (Fig. 2) . It is interesting that monoubiquitinated FANCD2 and monoubiquitinated PCNA specifically recruit nucleases-FAN1 and SNM1A, respectively-to the ICL site. Whether monoubiquitinated FANCD2 can recruit SNM1A, or whether monoubiquitinated PCNA can recruit FAN1, remains to be determined. The TLS polymerases Pol η and Rev1, which also have UBZ or ubiquitin-binding motif (UBM) domains, are recruited to monoubiquitinated PCNA 21, 22 and perhaps to monoubiquitinated FANCD2.
Other nucleases are also possible candidates. Recent evidence suggests that FANCD2 itself has intrinsic nuclease activity 23 . MLH1, found in complex with FAN1 (refs. 10,11), also has endonuclease activity 24 . Finally, other nucleases, such as the SLX4 complex [25] [26] [27] and the newly identified EXDL2 (ref. 10), may be required for efficient ICL repair. Importantly, the in vitro Xenopus system may prove useful in determining the precise function and timing of the nucleolytic events in ICL repair.
Several outstanding issues remain unresolved. First, previous studies indicated that FANCD2 monoubiquitination is required to recruit FANCD2 to chromatin 5 . However, monoubiquitinated FANCD2 is chromatin bound in foci, even in the absence of FAN1. This suggests that the ubiquitin moiety of FANCD2 may bind other chromatin-bound partners that also contain ubiquitin interaction n e w s a n d v i e w s motifs. Alternatively, because FAN1 preferentially binds monoubiquitinated FANCD2 (ref. 13) , the monoubiquitinated FANCI subunit of the FANCD2-FANCI complex may be critical for chromatin binding. Hence, the identification of other ubiquitin-binding partners for FANCD2 and FANCI will be important. Second, how the FAN1 and SNM1A nucleases are released from monoubiquitinated FANCD2 and monoubiquitinated PCNA is unknown, but the release may be accomplished by the USP1-UAF1 de ubiquitinating complex 28, 29 . Third, it remains unclear how FANCD2-FANCI regulates TLS machineries and whether nuclease events come before or after the TLS events 9 . Finally, it will be important to determine whether FAN1 is itself an FA gene (that is, a gene with biallelic germline mutations in FA patients) or it is somatically mutated or silenced in human cancers with ICL hypersensitivity.
